Crossmark

Controller and battery changes due to technical problems related to the HVAD® left ventricular assist device - a single center experience

Crossref DOI link: https://doi.org/10.1186/s13019-018-0759-9

Published Online: 2018-06-19

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Najjar, Emil https://orcid.org/0000-0001-8066-2423
Hallberg Kristensen, Ann

Thorvaldsen, Tonje

Hubbert, Laila

Svenarud, Peter

Dalén, Magnus

Månsson Broberg, Agneta

Lund, Lars H.
License Information

Text and Data Mining valid from 2018-06-19
More Information

Article History

Received: 19 February 2018

Accepted: 1 June 2018

First Online: 19 June 2018

Ethics approval and consent to participate

: The study complies with the Declaration of Helsinki and was approved by the regional ethical review board (Dnr2016/2576–32). There was no need to have informed consent since the study was a retrospective analysis of available data from patients with LVADs.

: LHL: No disclosures directly related to the present work. Unrelated disclosures are: Research grants from Astra Zeneca, Boston Scientific; consulting or speaker’s honoraria from Novartis, Astra Zeneca, Bayer, St Jude, Medtronic, HeartWare, Vifor Pharma.LH: No disclosures directly related to the present work. Unrelated disclosures are: speaker’s honoraria from MSD and Novartis.Other authors none.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.